Nanaomycin A

Research use only, not for human use.

Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A is a selective inhibitor of DNMT3B (IC50 = 500 nM).

Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A is a selective inhibitor of DNMT3B (IC50 = 500 nM). (In Vitro):Nanaomycin A inhibits in vitro growth of the human malaria parasite Plasmodium falciparum with an IC80 value of 33.1 nM. Nanaomycin A (10, 100, 1000, 10000 nM) had a distinct cytotoxic effect in HCT116 (colon), A549 (lung), and HL60 (bone marrow) human tumor cell lines. Nanaomycin A (5 μM) had an 18-fold relative induction. Nanaomycin A (0.5, 5 μM) revealed induction of RASSF1A protein expression in A549 cells.

Nanaomycin A (10-10000 nM; 72 hours) has a distinct cytotoxic effect in all three cell lines.Nanaomycin A (0.5, 5 μM; 72 hours) reveals induction of RASSF1A protein expression in A549 cells. Nanaomycin A (5 μM; 72 hours) has an 18-fold relative induction. Nanaomycin A not affects the enzymatic activity of DNMT1. Cell Cytotoxicity Assay Cell Line:HCT116 (colon), A549 (lung), and HL60 (bone marrow) human tumor cell lines Concentration:10, 100, 1000, 10000 nM Incubation Time:72 hours Result:Had a distinct cytotoxic effect in all three cell lines.Western Blot Analysis Cell Line:A549 cells Concentration:0.5, 5 μM Incubation Time:72 hours Result:Revealed induction of RASSF1A protein expression.RT-PCR Cell Line:A549 cells Concentration:5 μM Incubation Time:72 hours Result:Had an 18-fold relative induction.

——

——

Cell Cycle/DNA Damage

DNA/RNA Synthesis

Apoptosis| Nucleoside Antimetabolite/Analog

——

——

52934-83-5

302.282

C16H14O6

>98% (HPLC)

——

C[C@@H]1O[C@@H](CC(O)=O)CC2=C1C(=O)c1c(O)cccc1C2=O

——

(-20℃)

With Ice Pack

≥ 2 years